Resource4thePeople is also providing an information bank in which recent developments in the Tylenol litigation and information about acetaminophen products from medical researchers, news media and the FDA are posted at:
The recent petition to the United States Judicial Panel on Multidistrict Litigation was made by lawyers for 28 plaintiffs who have filed product liability lawsuits claiming that their use of Tylenol caused them to suffer liver damage or failure, according to a report in The Pennsylvania Record, the state’s legal journal.***
The Record reported that attorneys for the plaintiffs requested that the 28 cases currently pending against McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson be coordinated and consolidated at the federal courthouse in Philadelphia.
“All of the products liability cases referenced by the plaintiffs’ lawyers allege that McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” the Record reported from the filings.
The news site reported that a total of 21 of the 28 cases are currently pending in the U.S. District Court for the Eastern District of Pennsylvania, and although they were originally assigned randomly to various judges within that district, they have all since been reassigned by the court’s chief judge to U.S. District Judge Lawrence F. Stengel, reads the attorneys’ memorandum of law in support of their motion for transfer and coordination or consolidation.
The Record also reported that other Tylenol liver damage actions have been filed in eight different federal courts in Mississippi, California, New York, Florida, New Jersey and Mas
Copyright©2012 Vocus, Inc.
All rights reserved